• Home
  • RMPL Pharma LLP

RMPL Pharma LLP

About RMPL Pharma LLP

RMPL PHARMA LLP is a part of ROYAL group of companies whose inception dates back to 1944.  RMPL PHARMA LLP. is reputed and leading merchant exporters in India of an extensive range of pharmaceuticals (mainly Oncology and other specialized products ) to African, Gulf, European, & South East Asian countries. We are also engaged in wholesale distribution throughout India of specialized pharmaceuticals ( mainly Oncology products ) manufactured by reputed Indian & Multinational companies.
We ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile
Contact info
  • 022-22004057
  • Office no 2, 1st Floor, Sunbeam Chambers, Opp Liberty Cinema,, Mumbai, India
Show contact info Hide contact info
Meet us at

CPHI & PMEC India 2024

India Expo Centre, Greater Noida, Delhi NCR
26 Nov 2024 - 28 Nov 2024
View Exhibitor Profile

Products from RMPL Pharma LLP (100)

  • Inj. Canzatax 100 mg

    Product Inj. Canzatax 100 mg

    Inj. Paclitaxel 100 mg
  • INJ. CARMENDAN 12.5 MG

    Product INJ. CARMENDAN 12.5 MG

    LIVOSIMENDAN 12. MG INJECTION.
  • Inj. Melkeran 50 mg

    Product Inj. Melkeran 50 mg

    Inj. Melphalan 50 mg
  • Tab. Low-K

    Product Tab. Low-K

    POTASSIUM CHLORIDE TABLETS
  • Ves-ATRA Softgel

    Product Ves-ATRA Softgel

    Tretinoin Soft Gelatin Capsules.
  • INJ. MELKERAN 50 MG

    Product INJ. MELKERAN 50 MG

    - PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .
  • TAB. MELKERAN 2 MG

    Product TAB. MELKERAN 2 MG

    - PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .
  • INJ.LEUCOVORIN CALCIUM 50 MG

    Product INJ.LEUCOVORIN CALCIUM 50 MG

    - AN ACTIVE METABOLITE OF FOLIC ACID  ( ALSO CALLED  FOLINIC ACID AND CICTROVORUM FACTOR ), WHICH DOSE NOT REQUIRE METABOLISM BY DIHYDROFOLATE REDUCTASE , THE MOLECULAR TARGET OF FOLATE ANTAGONIST- TYPE CHEMOTHERAPEUTIC DRUGS.
  • INJ. HOLOFOS 2 MG

    Product INJ. HOLOFOS 2 MG

    - INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.
  • INJ. HOLOFOS 1 GM

    Product INJ. HOLOFOS 1 GM

    - INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.
  • INJ. 5 - FLU 500 MG

    Product INJ. 5 - FLU 500 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
  • INJ. 5 - FLU 250 MG

    Product INJ. 5 - FLU 250 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
show all 100 products

RMPL Pharma LLP Resources (1)

  • RMPL PHARMA LLP.

    Brochure RMPL PHARMA LLP.

    The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.